Bq. Lorena Salazar Aravena
Biochemist, University of Concepción

 
     
  Publications  
     
 
 

Salazar L, Aravena O, Contreras-Levicoy J, Pesce B, Catalan D, Zuniga R, Iruretagoyena M, Kalergis AM, Aguillón JC.
Short-term lipopolysaccharide stimulation induces differentiation of murine bone marrow-derived dendritic cells into a tolerogenic phenotype.

 
  

Pincheira J, Romero P, Marcelain K, Salazar L, de la Torre C.
G2 checkpoint-dependent DNA repair and its response to catalase in Down syndrome and control lymphocyte cultures.

 
 

Aguillón JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M.
Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution?

 
 

Llanos C, Soto L, Sabugo F, Bastías MJ, Salazar L, Aguillón JC, Cuchacovich M.
[The influence of -238 and -308 TNF alpha polymorphisms on the pathogenesis and response to treatment in rheumatoid arthritis][Article in Spanish]

 
 

Aguillón JC, Cruzat A, Contreras-Levicoy J, Dotte A, Pesce B, Aravena O, Salazar L, Catalán D, Abello P, Aguirre A, Llanos C, Cuchacovich M.
[Emergent therapies for rheumatoid arthritis][Article in Spanish]

 
 
 
 

Schiattino I, Villegas R, Cruzat A, Cuenca J, Salazar L, Aravena O, Pesce B, Catalán D, Llanos C, Cuchacovich M, Aguillón JC.
Multiple imputation procedures allow the rescue of missing data: an application to determine serum tumor necrosis factor (TNF) concentration values during the treatment of rheumatoid arthritis patients with anti-TNF therapy.

 
 
Pérez C, González FE, Pavez V, Araya AV, Aguirre A, Cruzat A, Contreras-Levicoy J, Dotte A, Aravena O, Salazar L, Catalán D, Cuenca J, Ferreira A, Schiattino I, Aguillón JC.
The -308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene and ex vivo lipopolysaccharide-induced TNF-alpha expression in patients with aggressive periodontitis and/or type 1 diabetes mellitus.
 
 
Aguillón JC, Contreras J, Dotte A, Cruzat A, Catalán D, Salazar L, Molina MC, Guerrero J, López M, Soto L, Salazar-Onfray F, Cuchacovich M.
[New immunological weapons for medicine in the 21st Century: biological therapy based on the use of the latest generation monoclonal antibodies][Article in Spanish]
 
 
Hagood JS, Mangalwadi A, Guo B, MacEwen MW, Salazar L, Fuller GM.
Concordant and discordant interleukin-1-mediated signaling in lung fibroblast thy-1 subpopulations.
 
 
Bustos P, Ulloa N, Calvo C, Muller D, Durán D, Martínez J, Salazar L, Quiroga A.
Monoclonal antibodies to human apolipoproteins: application to the study of high density lipoprotein subpopulations.